Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1312
Selected: 0
NCT IDTitle
NCT00146536Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
NCT03709225Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer
NCT06239220PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
NCT04781062Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer
NCT00644189Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma
NCT00165126Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
NCT00806715Iron Overload in Stem Cell Transplant Recipients
NCT00879034A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
NCT01397734Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
NCT01614821Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia
NCT00181558Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone
NCT05455294Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
NCT02675959Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
NCT03304756Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen
NCT06907797Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
NCT03065062Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
NCT02441686Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma
NCT00003966Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
NCT00165373rhEndostatin Protein Involving Pediatric Patients With Cancer
NCT00546156Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
NCT00675831Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies
NCT01582841Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
NCT00644202A Pilot Weight Control Intervention at HPHC
NCT00215501Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
NCT03638453Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention
NCT01596322International HIV Antiretroviral Adherence, Resistance and Survival
NCT02926729Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
NCT01773395GVAX vs. Placebo for MDS/AML After Allo HSCT
NCT02176031Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
NCT06176261DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
NCT00136461A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
NCT05726370Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
NCT01747551FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
NCT03929029Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma
NCT01221753Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT04421560Pembrolizumab, Ibrutinib and Rituximab in PCNSL
NCT03122717Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
NCT03668223The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer
NCT00911820Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
NCT02658396GO-203-2C + Bortezomib For Relapsed Or Refractory MM
NCT00251368Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia
NCT03328091Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)
NCT01596218Brentuximab Vedotin for Steroid Refractory GvHD
NCT02661815A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
NCT00782626Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
NCT05528263Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
NCT06782399Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma
NCT06786104Video Inspired Discussions About Ethical Outcomes in Pediatrics
NCT00645333Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer
NCT03093428Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC